Skip to main content

The Myeloproliferative Syndromes

  • Chapter
  • 138 Accesses

Part of the book series: Contemporary Hematology ((CH))

Abstract

The concept of myeloproliferative syndromes is used to describe the four major entities of chronic myelogenous leukemia, polycythemia vera, essential thrombocythemia, and osteomyelofibrosis, as well as some rarer syndromes. Common to all of these disorders is the autonomous proliferation of one or several hematopoietic cell lineages. The myeloproliferative disorders are malignant or clonal proliferation of myeloid stem cells, although the clinical presentation and course of these disorders is different. Often, several features of the myeloproliferative syndromes occur together (e.g., chronic myelogenous leukemia with osteomyelofibrosis or polycythemia with thrombocytosis).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • Carella AM, Lerma E, Corretti MT, et al. Autografting with Ph-mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. Blood 1999; 93: 1534–1539

    PubMed  CAS  Google Scholar 

  • Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myelogenous leukemia. N Engl J Med 1998; 338: 962–968.

    Article  PubMed  CAS  Google Scholar 

  • Lee SJ, Anasetti C, Horowitz MH, Antin JH. Initial therapy for chronic myelogenous leukemia: playing the odds. J Clin Oncol 1998; 16: 2897–2903.

    PubMed  CAS  Google Scholar 

  • Moliterno AR, Hankins D, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 1998; 338: 572–580.

    Article  PubMed  CAS  Google Scholar 

  • Nimer SD. Essential thrombocythemia: another “heterogeneous disease” better understood? Blood 1999; 93: 415–416.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Munker, R., Hiller, E., Paquette, R. (2000). The Myeloproliferative Syndromes. In: Modern Hematology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-203-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-203-6_8

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5873-3

  • Online ISBN: 978-1-59259-203-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics